NOdal METastasis in high risk Endometrial Cancer (NOMETEC) PART I: Mapping the lymphatic drainage of the uterus: a feasibility study of the sentinel node procedure.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON28134

Enrollment

Registered

2013-10-30

Start date

2012-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

(High Risk) Endometrial Cancer

Interventions

Diagnostic and pre-operative work-up of the participants will be in accordance with current clinical practice and protocols. During the ambulant hysteroscopic procedure submucosal injection (SMI) of 2

Eligibility

Inclusion criteria

Inclusion criteria: - All women, undergoing a diagnostic or therapeutic hysteroscopy because of suspicion for a (benign) lesion of the endometrium (polyps, small myoma, ...) - All women, undergoing a hysteroscopic curettage and a hysterectomy because of suspicion for a (malignant) lesion of the endometrium.

Exclusion criteria

Exclusion criteria: Contra-indication for hysteroscopy and/or open abdominal surgery and/or laparoscopic surgery: cervicitis, PID, severe cardiopulmonal or other co-morbidity.

Design outcomes

Primary

Measure	Time frame
Comparison of the two injection techniques considering their feasibility in mapping the pelvic and para-aortal lymphdrainage routes of the uterus. Primary outcome parameters: Total sentinel node detection rate per injection technique.	—

Secondary

Measure	Time frame
- Location of sentinel node detection: pelvic and/or para-aortal - level of para-aortal sentinel node detection (high and/or low)	—

Contacts

Public ContactE.A.E.M. Reynaers

Resident Obstetrics and Gynaecology University Medical Center Utrecht Heidelberglaan 100

e.a.e.reynaers-2@umcutrecht.nl088-7555555

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)